期刊文献+

猫杯状病毒高致病性毒株特性研究进展 被引量:1

Research Progress on the Characteristics of Virulent Systemic Feline Calicivirus
原文传递
导出
摘要 猫致死性全身系统性疾病(Virulent systemic disease,VSD)由猫杯状病毒高致病性毒株(Virulent systemic feline calicivirus,VS⁃FCV)引起。患猫感染后表现为全身性症状,累及多个器官组织,引起高致死率。由于尚未发现VS⁃FCV相应的临床和遗传标志物,且疫苗免疫效果有限,给猫杯状病毒的防治带来了新的挑战。本文通过综述VS⁃FCV引起的流行病学特征、临床特点、病原学特性和生物学特性方面的研究进展,对该毒株的判定方法进行讨论,以期为其临床诊断和相应疫苗的研发提供理论依据。 Feline virulent systemic disease(VSD)is caused by virulent systemic feline calicivirus(VS⁃FCV).Affected cats have systemic symptoms multiple organs damage,which causes a high mortality rate.The immune effect of the vaccine remains limitations because related clinical and genetic markers of VS⁃FCV have not been found yet,which brings new challenges to the prevention and treatment of feline calicivirus.In this paper,the method to determining the virus strain was discussed by reviewing the research progress in epidemiological,clinical,etiological,and biological features caused by VS⁃FCV,which aimed to provide a theoretical basis for its clinical diagnosis and the development of corresponding vaccines.
作者 桂亚萍 刘健 白艺兰 王建 赵洪进 GUI Yaping;LIU Jian;BAI Yilan;WANG Jian;ZHAO Hongjin(Shanghai Animal Disease Prevention and Control Center,Shanghai 201103,China)
出处 《病毒学报》 CAS CSCD 北大核心 2023年第4期1093-1098,共6页 Chinese Journal of Virology
关键词 猫杯状病毒高致病性毒株 致死性全身系统性疾病 Virulent systemic feline calicivirus Virulent systemic disease
  • 相关文献

参考文献8

二级参考文献33

  • 1黄倩倩,刘家森,田进,孔德生,曲连东.猫杯状病毒的分离鉴定及其对理化因素抵抗力的研究[J].中国兽医科学,2015,45(4):385-389. 被引量:7
  • 2De man marc M G,Ducatelle R V.Bilateral subcutaneous fibrosarcomas in a cat following feline parvo-,herpes-and calicivirus vaccination[J].Journal of Feline Medicine&Surgery,2007,9(5):432-434.
  • 3Jas D,Aeberle′C,Lacombe V,et al.Onset of immunity in kittens after vaccination with a non-adjuvanted vaccine against feline panleucopenia,feline calicivirus and feline herpesvirus[J].The Veterinary Journal,2009,182(1):86-93.
  • 4Poulet H,Jas D,Lemeter C,et al.Efficacy of a bivalent inactivated non-adjuvanted feline calicivirus vaccine:Relation between in vitro cross-neutralization and heterologous protection in vivo[J].Vaccine,2008,26(29/30):3647-3654.
  • 5Masubuchi K,Wakatsuki A,Iwamoto K,et al.Immunological and genetic characterization of feline caliciviruses used in the development of a new trivalent inactivated vaccine in Japan[J].J Vet Med Sci,2010,72(9):1189-1194.
  • 6Radford A D,Bennett M,Mcardle F,et al.The use of sequence analysis of a feline calicivirus(FCV)hypervariable region in the epidemiological investigation of FCV related disease and vaccine failures[J].Vaccine,1997,15(12/13):1451-1458.
  • 7Hohdatsu T,Sato K,Tajima T,et al.Neutralizing feature of commercially available feline calicivirus(FCV)vaccine immune sera against FCV field isolates[J].J Vet Med Sci,1999,61(3):299-301.
  • 8Porter C J,Radford A D,Gaskellr M,et al.Comparison of the ability of feline calicivirus(FCV)vaccines to neutralise a panel of current UK FCV isolates[J].Journal of Feline Medicine&Surgery,2008,10(1):32-40.
  • 9Kanellos T,Sutton D J,Salisbury C F,et al.Combined administration in a single injection of a feline multivalent modified live vaccine against FHV,FCV,and FPLV together with a recombinant FeLV vaccine is both safe and efficacious for all four major feline viral pathogens[J].Journal of Feline Medicine&Surgery,2008,10(4):346-354.
  • 10Huang C J,Hess J,Gill M,et al.A dual-strain feline calicivirus vaccine stimulates broader cross-neutralization antibodies than a single-strain vaccine and lessens clinical signs in vaccinated cats when challenged with a homologous feline calicivirus strain associated with virulent systemic disease[J].Journal of Feline Medicine&Surgery,2010,12(2):129-137.

共引文献18

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部